Skip to content

Expiring federal contract · order under a contract vehicle

75N91022F00001 — The Univeristy Of Texas M.d. Anderson Cancer Center

Department of Health and Human Services · National Institutes of Health

Contract / PIID
75N91022F00001
Incumbent
The Univeristy Of Texas M.d. Anderson Cancer Center
Incumbent UEI
S3GMKS8ELA16
Current end date
May 31, 2027
Potential total value
$1,121,090
Obligated
$1,121,090
NAICS
541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Set-aside
SB-Total
Start date
June 1, 2022
Place of performance
TX
Award type
DELIVERY ORDER

Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.

What the contract covers

PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS-- TARGETING THE PARP PATHWAY FOR THE PREVENTION OF BREAST CANCER

Likely rebid window (estimate)

  • Sources Sought / RFI: about May 2026 – Nov 2026 (6–12 months before the end date)
  • RFP: about Jan 2027 – Mar 2027 (2–4 months before the end date)

Now inside the estimated Sources Sought / RFI window.

This is an order under contract vehicle 75N91019D00021. Orders are usually not competed on their own: the next order may be placed under the same vehicle.

Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.

Track this recompete free

  • Change history: no changes recorded since Mindy began tracking this contract.
  • Alerts: get an email when the end date moves or the follow-on is posted.
  • Contacts: the buying office and small-business contacts for this agency.

Other contracts expiring at Department of Health and Human Services (NAICS 541714)